Measurements of myocardial metabolism in patients with ischemic heart disease

American Journal of Cardiology

Volumn 82, Issue 5 A, 1998, Pages

  Schelbert, Heinrich R ^a,b  

^a Division of Nuclear Medicine   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; CELL VIABILITY; CONFERENCE PAPER; CORONARY ARTERY BLOOD FLOW; ENZYME PHOSPHORYLATION; FATTY ACID METABOLISM; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE METABOLISM; HUMAN; HUMAN EXPERIMENT; ISCHEMIC HEART DISEASE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 0032480311     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00539-6     Document Type: Conference Paper

References (54)

1. Schelbert H. Principles of positron emission tomography. Skorton D., Schelbert H., Wolf G., Brundage B. Marcus' Cardiac Imaging. 2nd ed. 1996;1063-1092 WB Saunders, Philadelphia.
2. Heyndrickx G.R., Millard R.W., McRitchie R.J., Maroko P.R., Vatner S.F. Regional myocardial functional and electrophysiological alterations after brief coronary occlusion in conscious dogs. J Clin Invest. 56:1975;978-985.
3. Kloner R., Allen J., Cox T., Zheng Y., Ruiz C. Stunned left ventricular myocardium after exercise treadmill testing in coronary artery disease. Am J Cardiol. 68:1991;329-334.
4. Tillisch J., Brunken R., Marshall R., Schwaiger M., Mandelkern M., Phelps M., Schelbert H.R. Reversibility of cardiac wall motion abnormalities predicted by positron tomography. N Engl J Med. 314:1986;884-888.
5. Vanoverschelde J.-L., Wijns W., Depré C., Essamri B., Heyndrickx G.R., Borgers M., Bol A., Melin J.A. Mechanisms of chronic regional postischemic dysfunction in humans new insights from the study of noninfarcted collateral-dependent myocardium . Circulation. 87:1993;1513-1523.
6. Bolli R. The early and late phases of preconditioning against myocardial stunning and the essential role of oxyradicals in the late phase an overview . Basic Res Cardiol. 91:1996;57-63.
7. Rahimtoola S.H. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation. 72:1987;V123-V135.
8. 18F-labeled fluorodeoxyglucose and N-13 ammonia. Circulation. 67:1983;766-778.
9. Depré C., Melin J., Essamri B., Grandin C., Wijns W., Borgers M. Ultrastructural correlates of flow-metabolism mismatch pattern on positron emission tomography. (Abstr.) Circulation. 84:1991;II-90.
10. Maes A., Flameng W., Nuyts J., Borgers M., Shivalkar B., Ausma J., Bormans G., Schiepers C., De Roo M., Mortelmans L. Histological alterations in chronically hypoperfused myocardium correlation with PET findings . Circulation. 90:1994;735-745.
11. 11C-acetate and positron emission tomography. Circulation. 95:1997;1417-1424.
12. Maes A., Vlameng W., Borgers M., Nuyts J., Ausma J., Bormans G., Van de Werf F., De Roo M., Mortelmans L. Regional myocardial blood flow, glucose utilization and contractile function before and after revascularization and ultrastructural findings in patients with chronic coronary artery disease. Eur J Nucl Med. 22:1995;1299-1305.
13. Fedele F.A., Gewortz J., Capone R.J., Sharaf B., Most A.S. Metabolic response to prolonged reduction of myocardial blood flow distal to a severe coronary artery stenosis. Circulation. 78:1988;729-735.
14. Matsuzaki M., Gallagher K.P., Kemper W.S., White F., Ross J. Jr. Sustained regional dysfunction produced by prolonged coronary stenosis gradual recovery after reperfusion . Circulation. 68:1983;170-182.
15. Schulz R., Rose J., Martin C., Brodde O.-E., Heusch G. Development of short-term myocardial hibernation - its limitation by the severity of ischemia and inotropic stimulation. Circulation. 88:1993;684-695.
16. Chen C., Chen L., Fallon J., May L., Bow L., Knibbs D., McKay R., Gillam L., Waters D. Functional and structural alterations with 24-hour myocardial hibernation and recovery after reperfusion. Circulation. 94:1996;507-516.
17. Marinho N., Keogh B., Costa D., Lammertsma A., Ell P., Camici P. Pathophysiology of chronic left ventricular dysfunction. Circulation. 93:1996;737-744.
18. Sun K., Czernin J., Krivokapich J., Lau Y., Böttcher M., Maurer G., Phelps M., Schelbert H. Effects of dobutamine stimulation on myocardial blood flow, glucose metabolism and wall motion in normal and dysfunctional myocardium. Circulation. 94:1996;3146-3154.
19. Depré C., Vanoverschelde J.-L.J., Melin J., Borgers M., Bol A., Ausma J., Dion R., Wijns W. Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans. Am J Physiol. 268:1995;H1265-H1275.
20. Vanoverschelde J., Wijns W., Borgers M., Heyndrickx G., Depré C., Flameng W., Melin J. Chronic myocardial hibernation in humans from bedside to bench . Circulation. 95:1997;1961-1971.
21. Hashimoto T., Buxton D., Krivokapich J., Hansen H., Phelps M., Schelbert H. Responses of blood flow, oxygen consumption, and contractile function to inotropic stimulation in stunned canine myocardium. Am Heart J. 127:1994;1250-1262.
22. Schelbert H.R., Henze E., Schön H.R., Najafi A., Hansen H., Huang S.C., Barrio J.R., Phelps M.E. C-11 palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography. IV. In vivo demonstration of impaired fatty acid oxidation in acute myocardial ischemia. Am Heart J. 106:1983;736-750.
23. Schwaiger M., Brunken R., Grover-McKay M., Krivokapich J., Child J., Tillisch J.H., Phelps M.E., Schelbert H.R. Regional myocardial metabolism in patients with acute myocardial infarction assessed by positron emission tomography. J Am Coll Cardiol. 8:1986;800-808.
24. Renstrom B., Liedtke A., Nellis S. Mechanisms of substrate preference for oxidative metabolism during early reperfusion. Am J Physiol. 259:1990;H317-H323.
25. Chan S., Brunken R., Phelps M., Schelbert H. Use of the metabolic tracer C-11 acetate for evaluation of regional myocardial perfusion. J Nucl Med. 32:1991;665-672.
26. 11C] acetate and dynamic positron emission tomography. Circulation. 79:1989;134-142.
27. Vanoverschelde J., Melin J., Bol A., Vanbutsele R., Cogneau M., Labar D., Robert A., Michel C., Wijns W. Regional oxidative metabolism in patients after recovery from reperfused anterior myocardial infarction. Circulation. 85:1992;9-21.
28. Gropler R.J., Geltman E.M., Sampathkumaran K., Perez J.E., Schechtman K.B., Conversano A., Sobel B.E., Bergmann S.R., Siegel B.A. Comparison of carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomography. J Am Coll Cardiol. 22:1993;1587-1597.
29. 11C acetate in patients with old myocardial infarction usefulness of low-dose dobutamine infusion . Circulation. 94:1996;1834-1841.
30. Czernin J., Porenta G., Brunken R., Krivokapich J., Chen K., Bennett R., Hage A., Fung C., Tillisch J., Phelps M.E., Schelbert H.R. Regional blood flow, oxidative metabolism, and glucose utilization in patients with recent myocardial infarction. Circulation. 88:1993;884-895.
31. Gewirtz H., Fischman A., Abraham S., Gilson M., Strauss H., Alpert N. Positron emission tomographic measurements of absolute regional myocardial blood flow permits identification of nonviable myocardium in patients with chronic myocardial infarction. J Am Coll Cardiol. 23:1994;851-859.
32. 18fluoro-2-deoxyglucose and positron emission computed tomography. Kreuzer H., Parmley W.W., Rentrop P., Heiss H.W. Quantification of Myocardial Ischemia. 1980;437-447 Gehard Witzstrock Publishing House, New York.
33. Choi Y., Brunken R., Hawkins R., Huang S.-C., Buxton D., Hoh C., Phelps M., Schelbert H. Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans. Eur J Nucl Med. 20:1993;308-318.
34. Mäki M., Luotolahti M., Nuutila P., Iida H., Voipio-Pulkki L., Ruotsalainen U., Haaparanta M., Solin O., Hartiala J., Härkönen R., Knuuti J. Glucose uptake in the chronically dysfunctional but viable myocardium. Circulation. 93:1996;1658-1666.
35. Chan A., Czernin J., Brunken R.C., Choi Y., Krivokapich J., Schelbert H.R. Effects of fasting on the incidence of blood flow metabolism mismatches in chronic CAD patients. (Abstr.) J Am Coll Cardiol. 21:1993;129A.
36. Young L., Renfu Y., Russell R., Hu X., Caplan M., Ren J., Shulman G., Sinusas A. Low-flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo. Circulation. 95:1997;415-422.
37. Schwaiger M., Sun D., Deeb G., Nguyen N., Haas F., Sebening F., Brosius F.C. Expression of myocardial glucose transporter (GLUT) mRNAs in patients with advanced coronary artery disease (CAD). (Abstr.) Circulation. 90:1994;I-113.
38. Lopaschuk G., Stanley W. Glucose metabolism in the ischemic heart. Circulation. 95:1997;313-315.
39. Borgers M., Ausma J. Structural aspects of the chronic hibernating myocardium in man. Basic Res Cardiol. 90:1995;44-46.
40. Czernin J., Porenta G., Rosenquist G., Kuhle W., De Groof M., Krivokapich J., Brunken R., Mody F., Phelps M., Schelbert H. Loss of coronary perfusion reserve in PET ischemia. (Abstr.) Circulation. 84:1991;II-47.
41. 18F-2-deoxyglucose deposition and regional flow in pigs with chronically dysfunctional myocardium evidence for transmural variations in chronic hibernating myocardium . Circulation. 95:1997;1900-1909.
42. de Silva R., Yamamoto Y., Rhodes C.G., Iida H., Nihoyannopoulos P., Davies G.J., Lammertsma A.A., Jones T., Maseri A. Preoperative prediction of the outcome of coronary revascularization using positron emission tomography. Circulation. 86:1992;1738-1742.
43. Tamaki N., Yonekura Y., Yamashita K., Saji H., Magata Y., Senda M., Konishi Y., Hirata K., Ban T., Konishi J. Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol. 64:1989;860-865.
44. Tamaki N., Ohtani H., Yamashita K., Magata Y., Yonekura Y., Nohara R., Kambara H., Kawai C., Hirata K., Ban T., Kinishi J. Metabolic activity in the areas of new fill-in after thallium-201 reinjection comparison with positron emission tomography using fluorine-18-deoxyglucose . J Nucl Med. 32:1991;673-678.
45. Marwick T., Nemec J., Lafont A., Salcedo E., MacIntyre W. Prediction by postexercise fluoro-18 deoxyglucose positron emission tomography of improvement in exercise capacity after revascularization. Am J Cardiol. 69:1992;854-859.
46. Lucignani G., Paolini G., Landoni C., Zuccari M., Paganelli G., Galli L., Di Credico G., Vanoli G., Rossetti C., Mariani M.A., Gilardi M.C., Colombo F., Grossi A., Fazio F. Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease. Eur J Nucl Med. 19:1992;874-881.
47. Carrel T., Jenni R., Haubold-Reuter S., Von Schulthess G., Pasic M., Turina M. Improvement of severely reduced left ventricular function after surgical revascularization in patients with preoperative myocardial infarction. Eur J Cardiothorac Surg. 6:1992;479-484.
48. Bax J., Cornel J., Visser F., Fioretti P., Van Lingen A., Reijs A., Boersma E., Teule G., Visser C. Prediction of recovery of myocardial dysfunction after revascularization comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography. J Am Coll Cardiol. 28:1996;558-564.
49. vom Dahl J., Altehoefer C., Sheehan F., Buechin P., Uebis R., Messmer B., Buell U., Hanrath P. Recovery of regional left ventricular dysfunction after coronary revascularization impact of myocardial viability assessed by nuclear imaging and vessel patency at follow-up angiography . J Am Coll Cardiol. 28:1996;948-958.
50. Eitzman D.T., Al-Aouar Z., Von Dahl J., Kirsh M., Schwaiger M. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol. 20:1992;559-565.
51. Di Carli M., Davidson M., Little R., Khanna S., Mody F., Brunken R., Czernin J., Rokhsar S., Stevenson L., Laks H., Hawkins R., Schelbert H., Phelps M., Maddahi J. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol. 73:1994;527-533.
52. Lee K., Marwick T., Cook S., Go R., Fix J., James K., Sapp S., MacIntyre W., Thomas J. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Circulation. 90:1994;2687-2694.
53. Tamaki N., Kawamoto M., Takahashi N., Yonekura Y., Magata Y., Nohara R., Kambara H., Sasayama S., Hirata K., Ban T., Konishi J. Prognostic value of an increase in fluorine-18 deoxyglucose uptake in patients with myocardial infarction comparison with stress thallium imaging . J Am Coll Cardiol. 22:1993;1621-1627.
54. Di Carli M., Farbod A., Schelbert H., Brunken R., Laks H., Phelps M., Maddahi J. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation. 92:1995;3436-3444.